AP9801350A0 - Parasitical formulations. - Google Patents
Parasitical formulations.Info
- Publication number
- AP9801350A0 AP9801350A0 APAP/P/1998/001350A AP9801350A AP9801350A0 AP 9801350 A0 AP9801350 A0 AP 9801350A0 AP 9801350 A AP9801350 A AP 9801350A AP 9801350 A0 AP9801350 A0 AP 9801350A0
- Authority
- AP
- ARIPO
- Prior art keywords
- parasitical
- formulations
- administer
- convenient
- protection against
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000007943 implant Substances 0.000 abstract 2
- 239000004067 bulking agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 230000000590 parasiticidal effect Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9720228.7A GB9720228D0 (en) | 1997-09-23 | 1997-09-23 | Parasiticidal formulations |
| GBGB9810143.9A GB9810143D0 (en) | 1998-05-12 | 1998-05-12 | Parasiticidal formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP9801350A0 true AP9801350A0 (en) | 2000-03-17 |
Family
ID=26312302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1998/001350A AP9801350A0 (en) | 1997-09-23 | 1998-09-17 | Parasitical formulations. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1014970A1 (fr) |
| JP (1) | JP2001517622A (fr) |
| AP (1) | AP9801350A0 (fr) |
| AR (1) | AR013509A1 (fr) |
| AU (1) | AU9742298A (fr) |
| BR (1) | BR9812385A (fr) |
| CA (1) | CA2304283A1 (fr) |
| GT (1) | GT199800149A (fr) |
| MA (1) | MA24655A1 (fr) |
| PA (1) | PA8459501A1 (fr) |
| PE (1) | PE117199A1 (fr) |
| TN (1) | TNSN98175A1 (fr) |
| WO (1) | WO1999015166A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP279698A0 (en) * | 1998-04-03 | 1998-04-30 | Sunscape Developments Limited | Sustained release formulation |
| US6645192B2 (en) | 1998-09-30 | 2003-11-11 | Ivy Animal Health, Inc. | Pellet implant system for immediate and delayed release of antiparasitic drug |
| WO2001037811A1 (fr) * | 1999-11-22 | 2001-05-31 | Akzo Nobel N.V. | Compositions permettant de liberer un ingredient actif de façon predefinie et regulee, preparation et utilisation de ces compositions |
| US6953586B1 (en) | 2000-06-08 | 2005-10-11 | Ivy Animal Health, Inc. | Growth promoting pharmaceutical implant |
| DE10032878A1 (de) * | 2000-07-06 | 2002-01-17 | Bayer Ag | Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier |
| AUPR602401A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release delivery system |
| AUPR602501A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
| AUPR610501A0 (en) * | 2001-07-04 | 2001-07-26 | Smart Drug Systems Inc | Treatment of parasitic disease |
| US7918863B2 (en) | 2005-06-24 | 2011-04-05 | Conceptus, Inc. | Minimally invasive surgical stabilization devices and methods |
| WO2018226512A1 (fr) * | 2017-06-06 | 2018-12-13 | Merck Sharp & Dohme Corp. | Implant à action prolongée pour le traitement de maladies infectieuses |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0240274A3 (fr) * | 1986-04-03 | 1990-03-14 | Merck & Co. Inc. | Avermectine comme agents pour promotion de la croissance |
| US4847243A (en) * | 1987-10-08 | 1989-07-11 | Merck & Co., Inc. | Treatment for fescue toxicosis in grazing animals |
| NZ239370A (en) * | 1990-08-22 | 1994-04-27 | Merck & Co Inc | Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone |
| US5411737A (en) * | 1991-10-15 | 1995-05-02 | Merck & Co., Inc. | Slow release syneresing polymeric drug delivery device |
-
1998
- 1998-09-04 BR BR9812385-8A patent/BR9812385A/pt not_active IP Right Cessation
- 1998-09-04 EP EP98951367A patent/EP1014970A1/fr not_active Withdrawn
- 1998-09-04 WO PCT/EP1998/005720 patent/WO1999015166A1/fr not_active Ceased
- 1998-09-04 CA CA002304283A patent/CA2304283A1/fr not_active Abandoned
- 1998-09-04 AU AU97422/98A patent/AU9742298A/en not_active Abandoned
- 1998-09-04 JP JP2000512535A patent/JP2001517622A/ja active Pending
- 1998-09-17 AP APAP/P/1998/001350A patent/AP9801350A0/en unknown
- 1998-09-17 PA PA19988459501A patent/PA8459501A1/es unknown
- 1998-09-21 AR ARP980104712A patent/AR013509A1/es unknown
- 1998-09-22 MA MA25268A patent/MA24655A1/fr unknown
- 1998-09-22 TN TNTNSN98175A patent/TNSN98175A1/fr unknown
- 1998-09-22 GT GT199800149A patent/GT199800149A/es unknown
- 1998-09-22 PE PE1998000903A patent/PE117199A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1014970A1 (fr) | 2000-07-05 |
| JP2001517622A (ja) | 2001-10-09 |
| WO1999015166A1 (fr) | 1999-04-01 |
| PE117199A1 (es) | 1999-11-20 |
| CA2304283A1 (fr) | 1999-04-01 |
| PA8459501A1 (es) | 2000-05-24 |
| MA24655A1 (fr) | 1999-04-01 |
| TNSN98175A1 (fr) | 2005-03-15 |
| AR013509A1 (es) | 2000-12-27 |
| GT199800149A (es) | 2000-03-15 |
| AU9742298A (en) | 1999-04-12 |
| BR9812385A (pt) | 2000-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000041681A3 (fr) | FORMULATIONS DE MEDICAMENTS CONTENANT UN OPIOIDE ET UN α-AGONISTE | |
| MY118151A (en) | Pharmaceutical formulations containing voriconazole. | |
| BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
| AU1276501A (en) | Active ingredient combination having insecticidal and acaricidal characteristics | |
| BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
| AU7315301A (en) | Compounds and compositions for delivering active agents | |
| AU2001295017A1 (en) | Solid dose nanoparticulate compositions | |
| WO2002017918A3 (fr) | Formulations a liberation prolongee pour les secretagogues de l'hormone de croissance | |
| SI0991407T2 (en) | Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations | |
| ZA200003121B (en) | Flash-melt oral dose formulations. | |
| GB0025173D0 (en) | Therapeutic agents | |
| MXPA01008611A (es) | Compuestos y composiciones para suministrar agentes activos. | |
| IL146025A0 (en) | Improved pharmaceutical formulations comprising at least one hiv protease inhibiting compound | |
| SE0102843D0 (sv) | Stabilized oral pharmaceutical composition containing lodide and lodate and method | |
| AU2001284413A1 (en) | Medicinal compositions for preventing or treating heart failure | |
| AP9801350A0 (en) | Parasitical formulations. | |
| PT1121127E (pt) | Composicoes farmaceuticas orais contendo buprenorfina | |
| NO994431L (no) | Ny formulering | |
| WO2002015959A3 (fr) | Composes et compositions permettant de distribuer des agents actifs | |
| AU2002210407A1 (en) | Therapeutic vaccine formulations containing chitosan | |
| GB9907571D0 (en) | Compounds | |
| ZA200201807B (en) | Active ingredient combinations having insecticidal and acaricidal properties. | |
| AU2001291133A1 (en) | Methods of decreasing or preventing pain using spicamycin derivatives | |
| AU2002218077A1 (en) | Formulation for crop protection with insecticidal and acaricidal action | |
| BG104692A (en) | Extended release tiagabine formulation |